Global

Dr. Nathalie Bloch, head of big data and AI at the ARC Innovation Center at Sheba Medical Center, Israel, discusses the use of AI in dealing with COVID-19 patients in this episode of The Alessi Agenda.

Dr. Roy Schoenberg, CEO of Amwell, describes how COVID-19 is impacting his telehealth company and is rewriting the expectations for virtual care.

Biofourmis founder and CEO Kuldeep Singh Rajput discusses remote monitoring's role in reaching patients at home and reducing contact with COVID-19-positive patients.

Joel Diamond, MD, CMO of 2bPrecise, discusses pharmacogenomics as a good entry point for providers in precision medicine, identifying the right medicine for better outcomes and patient satisfaction.

Technology issues for interoperability are more of a cultural than a deployment challenge, explain Drew Ivan, Lyniate's chief product and strategy officer, and Matthew Michela, CEO of Life Image.

Consumer-centric healthcare means patients have access to their cost and data and are part of the discussions with their doctors about their healthcare options.

HIMSS Director of Privacy and Security Lee Kim offers insights and advice for health systems as they try to defend against not only the coronavirus pandemic but also the opportunistic cyberattacks that are using it as cover to sow chaos.

Patient engagement technology is helping the 72-practice Community Care Physicians medical group improve its no-show rate, send COVID-related newsletters to patients and remind them of their telehealth appointments during the pandemic.

In this HIMSS TV Deep Dive, we show how health systems are leveraging advanced technologies such as AI, analytics and telehealth to manage patient populations while still staying focused on the basic building blocks of health and wellness.

Patient Orator founder and CEO Kistein Monkhouse discusses the long history of racial inequalities in healthcare, and how technology can pinpoint those with the highest risk.